Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (21)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by van Ampting, J. M. A.
Right arrow Articles by Beutler, J. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van Ampting, J. M. A.
Right arrow Articles by Beutler, J. J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nephrol Dial Transplant (2003) 18: 1147-1151
© 2003 European Renal Association-European Dialysis and Transplant Association

Prevalence of atherosclerotic renal artery stenosis in patients starting dialysis

Jacobine M. A. van Ampting1, Erik L. Penne1, Frederik J. A. Beek2, Hein A. Koomans1, Walther H. Boer1 and Jaap J. Beutler1,

1 Department of Nephrology and Hypertension, and 2 Department of Radiology, University Medical Center Utrecht, Utrecht, The Netherlands

Background. Atherosclerotic renal artery stenosis (ARAS) can lead to end-stage renal failure (ESRF). We determined the prevalence of ARAS in patients 45 years of age or older starting renal replacement therapy.

Methods. Forty-nine of 80 consecutive patients (37 males, 12 females) starting renal replacement therapy in our centre gave informed consent and underwent spiral computed tomographic angiography of their renal arteries. A renal artery diameter reduction of 50% or more assessed by two radiologists was considered as a significant stenosis.

Results. Twenty of 49 patients (41%) had an ARAS, and in eight cases (16%) this was bilateral or unilateral with a single kidney. Women were more likely to have an ARAS than men; 75 (9/12) vs 30% (11/37, P<0.01). However, relatively more women declined participation. Non-participants and participants did not differ in respect to other relevant clinical data. Nonetheless, findings in these patients would be negative, the prevalence of ARAS would still be 31% in women and 22% in men (NS). In 13 patients with ARAS the registered diagnosis of ESRF either was hypertension, renovascular disease or unknown. Assuming that in these patients atherosclerotic renovascular disease was the cause of renal failure, a total of 13 patients (13/49, 27%) entered the dialysis programme because of this problem.

Conclusions. These results suggest that ARAS is an important cause of ESRF.

Keywords: atherosclerosis; renal artery stenosis; renal failure; renal replacement therapy

Correspondence and offprint requests to: Dr Jaap J. Beutler, Department of Nephrology and Hypertension, University Medical Center Utrecht, Room F03.226, PO Box 85500, 3508 GA Utrecht, The Netherlands. Email: j.j.beutler{at}azu.nl


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
VASC ENDOVASCULAR SURGHome page
M. C. Bates, J. E. Campbell, M. Broce, P. S. Lavigne, and M. A. Riley
Serum Creatinine Stabilization Following Renal Artery Stenting
Vascular and Endovascular Surgery, March 1, 2008; 42(1): 40 - 46.
[Abstract] [PDF]


Home page
CirculationHome page
H. Guo, P. A. Kalra, D. T. Gilbertson, J. Liu, S.-C. Chen, A. J. Collins, and R. N. Foley
Atherosclerotic Renovascular Disease in Older US Patients Starting Dialysis, 1996 to 2001
Circulation, January 2, 2007; 115(1): 50 - 58.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
A. Losito, R. Errico, P. Santirosi, T. Lupattelli, G. B. Scalera, and L. Lupattelli
Long-term follow-up of atherosclerotic renovascular disease. Beneficial effect of ACE inhibition
Nephrol. Dial. Transplant., August 1, 2005; 20(8): 1604 - 1609.
[Abstract] [Full Text] [PDF]


Home page
PERSPECT VASC SURG ENDOVASC THERHome page
J. Ayerdi and K. J. Hodgson
Balloon Angioplasty and Stenting for Renovascular Occlusive Disease
Perspectives in Vascular Surgery and Endovascular Therapy, March 1, 2004; 16(1): 25 - 38.
[Abstract] [PDF]


Home page
Nephrol Dial TransplantHome page
J. M. A. van Ampting, H. A. Koomans, and J. J. Beutler
Reply
Nephrol. Dial. Transplant., January 1, 2004; 19(1): 261 - 261.
[Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
J. Main and C. Wroe
Atherosclerotic renal artery stenosis in patients starting dialysis: an emperor with no clothes
Nephrol. Dial. Transplant., January 1, 2004; 19(1): 260 - 261.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.